← Investments

Portfolio company

StimCardio

United States · £23.7m raised

Raised

£23.7m

Latest stage

Series A

Rounds recorded

1

Backed by

2 investors

Sectors

Digital Health

About

This company develops non-invasive wearable neuromodulation devices for patients with atrial fibrillation to reduce heart arrhythmia recurrence following medical procedures.

Source

Funding history · 1

Similar companies